| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8612640 | Clinical Breast Cancer | 2018 | 32 Pages |
Abstract
OS from initial breast cancer diagnosis significantly improved over time for patients with HER2-positive breast cancer who develop BCBM, now exceeding 7 years; survival from BCBM diagnosis may now exceed 2 years.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Louisa A. Mounsey, Allison M. Deal, Kevin C. Keith, Julia M. Benbow, Shlomit S. Shachar, Timothy Zagar, E. Claire Dees, Lisa A. Carey, Matthew G. Ewend, Carey K. Anders,